Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Quick-acting orally disintegrating tablet and powder based on novel porous lactose and microcrystalline mannitol auxiliary materials

A technology of alcohol excipients and mannitol, which is applied in the field of quick-acting orally disintegrating tablets and powders, can solve the problems of unfavorable safety audit and toxicology research, lack of novelty, short development history of orally disintegrating tablets, etc.

Inactive Publication Date: 2019-05-10
谭淞文
View PDF10 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the lactose and mannitol used in the prior art are block-shaped grinding and sieving granules, and lactose and mannitol are mostly used as fillers, which have little effect on drug release
[0005] The development history of orally disintegrating tablets is relatively short, and the above conventional preparation methods have been registered in large quantities internationally, making it difficult to make creative achievements in drug improvement; and the improvement of drug formulations, such as changing the ratio of traditional Chinese medicine formulas, changing the ratio of excipients and mixing, is relatively lacking. Novelty; using too many excipients and components at the same time is not conducive to safety audit and toxicology research, and increases clinical difficulty

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Quick-acting orally disintegrating tablet and powder based on novel porous lactose and microcrystalline mannitol auxiliary materials
  • Quick-acting orally disintegrating tablet and powder based on novel porous lactose and microcrystalline mannitol auxiliary materials
  • Quick-acting orally disintegrating tablet and powder based on novel porous lactose and microcrystalline mannitol auxiliary materials

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Based on the quick-acting orally disintegrating tablet and powder of the novel porous lactose and microcrystalline mannitol excipients, this embodiment provides a preparation step of acetaminophen quick-acting orally disintegrating tablet and powder, including:

[0034] S1: Dissolve acetaminophen in ethanol solvent to obtain 22.5g / L acetaminophen ethanol solution;

[0035] S2: The amorphous lactose obtained by spray drying is added to the acetaminophen ethanol solution prepared by S1 at a concentration of 10g / L, and the novel porous lactose is obtained by crystallization, and the adsorption of the active pharmaceutical ingredients is completed;

[0036] S3: With the ratio of mannitol to ethanol of 1g:200mL (ie 5g / L), add 0.5g / mL mannitol aqueous solution to the ethanol mixed solution prepared by S2, which is a cotton-absorbent solid-ethanol mixed matrix;

[0037] S4: After the obtained mixture is dried, 0.5 g of the obtained solid is compressed into tablets or ground into powder...

Embodiment 2

[0040] Based on the quick-acting orally disintegrating tablets and powders of the novel porous lactose and microcrystalline mannitol excipients, this embodiment provides a preparation step of aspirin (also called acetylsalicylic acid) quick-acting orally disintegrating tablets and powders, including:

[0041] S1: Add the heated and dissolved 1g / mL lactose aqueous solution to the ethanol solution at a ratio of 1:50 (volume ratio) to prepare the new porous lactose, which is separated for use; with the ratio of mannitol to ethanol of 1g:100-500mL, Add 0.5 g / mL mannitol aqueous solution to the ethanol solution to prepare the microcrystalline mannitol, which is separated for use;

[0042] S2: Dissolve acetylsalicylic acid in an ethanol solvent to obtain 80g / L of an ethanol solution containing acetylsalicylic acid, and mix with 43g of new porous lactose prepared by S1 per liter to complete drug adsorption;

[0043] S3: Mix the microcrystalline mannitol made from S1 with ethanol at a ratio ...

Embodiment 3

[0047] Based on the quick-acting orally disintegrating tablet and powder of the novel porous lactose and microcrystalline mannitol excipient, this embodiment provides a preparation step of a caffeine quick-acting orally disintegrating tablet and powder, which includes:

[0048] S1: Dissolve or disperse 5g / L caffeine in an ethanol solvent to obtain an ethanol solution containing active pharmaceutical ingredients;

[0049] S2: With a ratio of mannitol to ethanol of 1g:250mL (ie 4g / L), add 0.5g / mL mannitol aqueous solution to the above ethanol mixed solution to form a cotton-absorbent solid-ethanol mixed matrix;

[0050] S3: After the obtained mixture is dried, the obtained solid is compressed into tablets or ground into powder.

[0051] The caffeine fast-acting orally disintegrating tablets and powders obtained by the above method contain ~56% by mass of the active pharmaceutical ingredient (ie API), 0% by mass of the new porous lactose, and ~44% by mass of microcrystalline mannose It s...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sizeaaaaaaaaaa
Sizeaaaaaaaaaa
Aperture diameteraaaaaaaaaa
Login to View More

Abstract

The invention provides a quick-acting orally disintegrating tablet and powder based on novel porous lactose and microcrystalline mannitol auxiliary materials, which is prepared from the following components in parts by mass: 0.5-60% of active pharmaceutical ingredient, 0-99.5% of the novel porous lactose (anhydrous alpha / beta mixed crystal lactose), 0-99.5% by mass of the microcrystalline mannitol(alpha / delta-mannitol mixed crystals) ; the quick-acting orally disintegrating tablet and powder based on the novel porous lactose and the microcrystalline mannitol auxiliary materials can be completely dissolved in the mouth within 2 seconds to 5 minutes, and effectively release active medicinal ingredients. The quick-acting orally disintegrating tablet and powder aims at the physical changes ofthe lactose and mannitol, so that the effect of uniformly and quickly releasing the orally disintegrating tablets is achieved; the method is practical in technology and can be industrialized easily.The quick-acting orally disintegrating tablet and powder directly or indirectly upgrades all existing orally disintegrating tablets and powders using the lactose and / or mannitol by upgrading auxiliarymaterials of the orally disintegrating tablets and powders.

Description

Technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to a quick-acting orally disintegrating tablet and powder based on novel porous lactose and microcrystalline mannitol auxiliary materials. Background technique [0002] Orally disintegrating tablet is a new type of drug tablet that can quickly dissolve in saliva in the oral cavity. It is suitable for children, the elderly, the handicapped, stomach damage, difficulty swallowing medicine, mental illness, epilepsy patients, Alzheimer's disease, etc. It is also especially suitable for the case where the drug needs to be absorbed directly into the blood under the tongue. To achieve rapid dissolution, the powder used to prepare the tablet can also be used as a powder alone and taken directly. [0003] One of the most commonly used formulation techniques for orally disintegrating tablets is to make the drug into an amorphous form. For example, Poovizhi Ponnammal et al. published "Orall...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/20A61K9/14A61K47/10A61K47/26
Inventor 谭淞文刘敏陈训财谭旭
Owner 谭淞文
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products